115 related articles for article (PubMed ID: 4151332)
1. The effect of parenteral indoramin on peripheral blood flow in patients with Raynaud's disease or atherosclerosis associated with intermittent claudication.
Fares CM; Milliken JC
Curr Med Res Opin; 1974; 2(2):57-62. PubMed ID: 4151332
[No Abstract] [Full Text] [Related]
2. A new atraumatic isotope-labelling technique for the assessment of digital cutaneous blood-flow.
Fox MJ; Milliken JC
Br J Surg; 1972 Apr; 59(4):312. PubMed ID: 5020773
[No Abstract] [Full Text] [Related]
3. Effect of indoramin on finger circulation in patients with Raynaud disease.
Clement DL; Duprez D; De Pue N
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S84-7. PubMed ID: 2423806
[TBL] [Abstract][Full Text] [Related]
4. Treatment of peripheral arterial insufficiency with inositoli nicotinas (Hexanicit).
Hentzer E
Scand J Clin Lab Invest Suppl; 1967; 99():226-32. PubMed ID: 4862834
[No Abstract] [Full Text] [Related]
5. Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin.
Stranden E; Roald OK; Krohg K
Br Med J (Clin Res Ed); 1982 Oct; 285(6348):1069-71. PubMed ID: 6812750
[TBL] [Abstract][Full Text] [Related]
6. Acute effects of misoprostol on digital circulation in patients with Raynaud's phenomenon.
Wise RA; Wigley F
J Rheumatol; 1994 Jan; 21(1):80-3. PubMed ID: 8151594
[TBL] [Abstract][Full Text] [Related]
7. Cold fingers, cold toes? Could be Raynaud's.
Harv Womens Health Watch; 2009 Mar; 16(7):4-5. PubMed ID: 19402237
[No Abstract] [Full Text] [Related]
8. Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon.
Bunker CB; Reavley C; O'Shaughnessy DJ; Dowd PM
Lancet; 1993 Jul; 342(8863):80-3. PubMed ID: 8100913
[TBL] [Abstract][Full Text] [Related]
9. Role of digital artery adrenoceptors in Raynaud's disease.
Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
[TBL] [Abstract][Full Text] [Related]
10. Raynaud's: the big chill for fingers and toes. Blood vessel spasms can make the cold a painful experience.
Harv Heart Lett; 2010 Feb; 20(6):3. PubMed ID: 20376945
[No Abstract] [Full Text] [Related]
11. Efficacy and tolerability of a selective alpha(2C)-adrenergic receptor blocker in recovery from cold-induced vasospasm in scleroderma patients: a single-center, double-blind, placebo-controlled, randomized crossover study.
Wise RA; Wigley FM; White B; Leatherman G; Zhong J; Krasa H; Kambayashi J; Orlandi C; Czerwiec FS
Arthritis Rheum; 2004 Dec; 50(12):3994-4001. PubMed ID: 15593189
[TBL] [Abstract][Full Text] [Related]
12. [The influence of isosorbide mononitrate on skin blood flow in patients with Raynaud's syndrome].
Gross R; Galus K; Zajac S; Jedrasik M
Wiad Lek; 2002; 55(1-2):29-34. PubMed ID: 12043312
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of indoramin, a new antihypertensive agent.
Lewis PJ; George CF; Dollery CT
Eur J Clin Pharmacol; 1973 Dec; 6(4):211-6. PubMed ID: 4359995
[No Abstract] [Full Text] [Related]
14. Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor.
Seibold JR; Jageneau AH
Arthritis Rheum; 1984 Feb; 27(2):139-46. PubMed ID: 6365102
[TBL] [Abstract][Full Text] [Related]
15. Effect of indoramin on finger blood flow in vasospastic patients.
Clement DL
Eur J Clin Pharmacol; 1978 Dec; 14(5):331-3. PubMed ID: 729626
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Raynaud's phenomenon with calcium channel blockers.
Smith CR; Rodeheffer RJ
Am J Med; 1985 Feb; 78(2B):39-42. PubMed ID: 3976694
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.
Kramer R; Rosendorff C; Bloom D
S Afr Med J; 1974 Aug; 48(37):1569-72. PubMed ID: 4851044
[No Abstract] [Full Text] [Related]
18. [Reserpine administration by retrograde intravenous route in patients with Raynaud's phenomenon].
Acevedo A; Arinoviche R; Palma A; Olea E; Guzmán G; Arriagada M; Grisanti M; Testar R
Rev Med Chil; 1982 Nov; 110(11):1063-5. PubMed ID: 7184095
[No Abstract] [Full Text] [Related]
19. [Classification of Raynaud's phenomenon].
Ratner GL; Slutsker GE
Vestn Khir Im I I Grek; 1989 Sep; 143(9):62-3. PubMed ID: 2617792
[No Abstract] [Full Text] [Related]
20. Hypertensive patients with Raynaud's phenomenon or intermittent claudication and their treatment with ketanserin.
van Oene JC
Drugs; 1988; 36 Suppl 1():148-51. PubMed ID: 3240729
[No Abstract] [Full Text] [Related]
[Next] [New Search]
